Viewing Study NCT03206918

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 5:03 AM
Ignite Modification Date: 2026-06-15 @ 5:10 AM
Study NCT ID: NCT03206918
Status: COMPLETED
Last Update Posted: 2024-10-26
First Post: 2017-06-29
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Efficacy and Safety of Zanubrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Sponsor: BeiGene
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsed or Refractory Chronic Lymphocytic Leukemia View
None Relapsed or Refractory Small Lymphocytic Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Bruton's tyrosine kinase View
None Chronic lymphocytic leukemia View
None Relapsed/refractory View
None Zanubrutinib View